Previous studies have shown that the transcription factor c‐Myc is the target of bromodomain proteins.44, 45 Furthermore, FBW7 controls proteasome‐mediated degradation of c‐Myc.46, 47 Thus, c‐Myc may also be involved in FBW7‐mediated BETi resistance in breast cancer. The gene discussed is FBXW7; the disease is breast carcinoma.